Revolutionizing Organ Transplants with Bioprinting | Ali Khademhosseini, CEO & Founding Director, Terasaki Institute for Biomedical Innovation

Dr. Ali is pioneering a medical revolution—developing fully transplantable, 3D-printed organs with cutting-edge bioprinting, CRISPR, and AI. With major backing, his team aims to create functional, cost-effective human livers within five years. This innovation could transform medicine, making organ shortages a thing of the past.00:09- About Ali KhademhosseiniHe is the CEO and Director of the Terasaki Institute for Biomedical Innovation in Los Angeles which is continuing the legacy of the transplant pioneer Paul Terasaki.